![](bg7.png)
REFERENCES
Ahren B., 2011. The dynamic incretin adaptation and type
2 diabetes. The Journal of Clinical Endocrinology
and Metabolism, Vol 96(3), pp. 620–622.
Bergman R. N., Phillips L. S., Cobelli C., 1981.
Physiologic evaluation of factors controlling glucose
tolerance in man: measurement of insulin sensitivity
and beta-cell glucose sensitivity from the response to
intravenous glucose. The Journal of Clinical
Investigation, Vol 68, pp. 1456–1467.
Bergman R. N., Ider Y. Z., Bowden C. R., Cobelli C.,
1979. Quantitative estimation of insulin sensitivity.
American Journal of Physiology: Endocrinology and
Metabolism, Vol 236, pp. E667–E677.
Brubaker P. L., Ohayon E. L., D’Alessandro L. M.,
Norwich K. H., 2007. A Mathematical Model of the
Oral Glucose Tolerance Test Illustrating the Effects
of the Incretins. Annals of Biomedical Engineering,
35(7), pp. 1286–1300.
Cobelli C., Man C. D., Toffolo G., Basu R., Vella A.,
Rizza R., 2014. The Oral Minimal Model Method.
Diabetes, Vol 63, pp. 1203-1213.
De Gaetano A., Panunzi S., Matone A., Samson A.,
Vrbikova J., Bendlova B., Pacini G., 2013. Routine
OGTT: A Robust Model Including Incretin Effect
for Precise Identification of Insulin Sensitivity and
Secretion in a Single Individual. PLOS ONE, Vol
8(8), pp. 1-16.
Kartono A., 2013. Modified minimal model for effect of
physical exercise on insulin sensitivity and glucose
effectiveness in type 2 diabetes and healthy human.
Theory in Biosciences, Vol 132(3), pp. 195-206.
Kaur K., Gautam C.S., 2006. Development of new incretin
drugs: Promising therapies. The Indian Journal of
Pharmacology, Vol 38(2), pp. 100-106.
Kim M., Oh T. J., Lee J. C., Choi K., Kim M. Y., Kim H.
C., Cho Y. M., Kim S., 2014. Simulation of Oral
Glucose Tolerance Tests and the Corresponding
Isoglycemic Intravenous Glucose Infusion Studies
for Calculation of the Incretin Effect. Journal of
Korean Medical Science, Vol 29, pp. 378-385.
Lim M. H., Oh T. J., Choi K., Lee J. C., Cho Y. M., Kim
S., 2016. Application of the Oral Minimal Model to
Korean Subjects with Normal Glucose Tolerance
and Type 2 Diabetes Mellitus. Diabetes &
Metabolism Journal, Vol 40(4), pp. 308-317.
Michaliszyn S. F., Mari A., Lee S. J., Bacha F., Tfayli H.,
Farchoukh L., Ferrannini E., Arslanian S., 2014. β-
Cell Function, Incretin Effect, and Incretin
Hormones in Obese Youth Along the Span of
Glucose Tolerance from Normal to Prediabetes to
Type 2 Diabetes. Diabetes, Vol 63, pp. 3846–3855.
Møller J. B., 2012. Model-Based Analysis of Ethnic
Differences in Type 2 Diabetes. Ph.D. thesis,
Technical University of Denmark.
Salinari S., Bertuzzi A., Mingrone G., 2011. Intestinal
transit of a glucose bolus and incretin kinetics: a
mathematical model with application to the oral
glucose tolerance test. American Journal of
Physiology: Endocrinology and Metabolism, Vol
300, pp. E955–E965.
Seike M., Saitou T., Kouchi Y., Ohara T., Matsuhisa M.,
Sakaguchi K., Tomita K., Kosugi K., Kashiwagi A.,
Kasuga M., Tomita M., Naito Y., Nakajima H.,
2011. Computational assessment of insulin secretion
and insulin sensitivity from 2-h oral glucose
tolerance tests for clinical use for type 2 diabetes.
The Journal of Physiological Sciences,Vol 61, pp.
321–330.
Tura A., Muscelli E., Gastaldelli A., Ferrannini E., Mari
A., 2014. Altered pattern of the incretin effect as
assessed by modelling in individuals with glucose
tolerance ranging from normal to diabetic.
Diabetologia, Vol 57, pp. 1199–1203.
Vilsbøll T., Holst J. J., 2004. Incretins, insulin secretion
and Type 2 diabetes mellitus. Diabetologia, Vol 47,
pp. 357–366.
Wilbaux M., Wölnerhanssen B. K., Gerspach, C.
Beglinger A. C. M., Pfister M., 2017. Characterizing
the dynamic interaction among gastric emptying,
glucose absorption, and glycemic control in
nondiabetic obese adults. American Journal of
Physiology: Regulatory, Integrative and
Comparative Physiology, Vol 312, pp. R314–R323.
EIC 2018 - The 7th Engineering International Conference (EIC), Engineering International Conference on Education, Concept and
Application on Green Technology
286